NCT02300688View on ClinicalTrials.gov

Bioequivalence Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Chronic Hepatitis B
Interventions
DRUG

Treatment A

administration of 1 time administration of the test drug (Treatment A)

DRUG

Treatment B

administration of 1 time administration of the reference drug (Treatment B)

Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT02300688 - Bioequivalence Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter